Torres-Ambriz P, Hurtado-López LM, Martínez-Duncker C

Language: Spanish
References: 21
Page: 92-95
PDF size: 95.90 Kb.

ABSTRACT

Thyroid nodules are a common clinical problem. The need to effectively distinguish between malignant and benign nodules becomes important to avoid expensive and unnecessary procedures and/or treatment of patients with benign thyroid disease as well as to assure appropriate and timely management of patients with thyroid cancer. All available data confirms that post-test likelihood for cancer, in the setting of a negative MIBI scan, is 0%. A negative MIBI scan excludes differentiated thyroid cancer and medullary cancer in all patients with a hypofunctioning thyroid nodule (negative predictive value is 100%). Patients with a hypofunctioning thyroid nodule and differentiated thyroid cancer or medullary cancer are › 98% of all primary thyroid cancer patients. Available data indicates that a patient with a HTN and a negative MIBI scan in whom there is no clinical or other reason to consider anaplastic thyroid cancer can have total peace of mind regarding the possibility of thyroid cancer.

REFERENCES

1. Segev DL, Clark DP, Zeiger MA, Umbricht C. Beyond the suspicious thyroid fine needle aspirate. Acta Cytol 2003; 47: 709-722.

2. Wang HH. Reporting thyroid fine-needle aspiration: literature review and a proposal. Diagn Cytopathol 2006; 34: 67-76.

3. Chao TC, Lin JD, Chao HH, Hsueh C, Chen MF. Surgical treatment of solitary thyroid nodules via fine-needle aspiration biopsy and frozen-section analysis. Ann Surg Oncol 2007; 14: 712-718.

4. Rosen JE, Stone MD. Contemporary diagnostic approach to the thyroid nodule. J Surg Oncol 2006; 94: 649-661.

5. Sahin M, Gursoy A, Tutuncu NB, Guvener DN. Prevalence and prediction of malignancy in cytologically indeterminate thyroid nodules. Clin Endocrinol (Oxf) 2006; 65: 514-518.

6. Tamsel S, Demirpolat G, Erdogan M, Nart D, Karadeniz M, Uluer H, Ozgen AG. Power Doppler US patterns of vascularity and spectral Doppler US parameters in predicting malignancy in thyroid nodules. Clin Radiol 2007; 62: 245-251.

7. Frates MC, Benson CB, Doubilet PM, Cibas ES, Marqusee E. Can color Doppler sonography aid in the prediction of malignancy of thyroid nodules? J Ultrasound Med 2003; 22: 127-131.

8. Iannuccilli JD, Cronan JJ, Monchik JM. Risk for malignancy of thyroid nodules as assessed by sonographic criteria: the need for biopsy. J Ultrasound Med 2004; 23: 1455-1464.

9. Kresnik E, Gallowitsch HJ, Mikosch P, Gómez I, Lind P. Technetium-99m-MIBI scintigraphy of thyroid nodules in an endemic goiter area. J Nucl Med 1997; 38(1): 62-65.

10. Erdil TY, Ozker K, Kabasakal L, Kanmaz B, Sonmezoglu K, Atasoy KC, Turoglu HT, Uslu I, Isitman AT, Onsel C. Correlation of technetium-99m MIBI and thallium-201 retention in solitary cold thyroid nodules with postoperative histopathology. Eur J Nucl Med 2000; 27(6): 713-720.

11. Sarikaya A, Huseyinova G, Irtanoglu ME, Erkmen N, Cermik TF, Berkarda S. The relation ship between 99Tc(m)-sestamibi uptake and ultrastructural cell types of thyroid tumors. Nucl Med Commun 2001; 22(1): 39-44.

12. Mezosi E, Bajnok L, Gyory E, Varga J, Sztojka I, Szabo J, Galuska L, Leovey A, Kakuk G, Nagy E. The role of technetium-99m methoxyisobutylisonitrile scintigraphy in the differential diagnosis of cold thyroid nodules. Eur J Nucl Med 1999; 26(8): 798-803.

13. Demirel K, Kapucu O, Yucel C, Ozdemir H, Ayvaz G, Taneri F. A comparison of radionuclide thyroid angiography, (99m)Tc-MIBI scintigraphy and power Doppler ultrasonography in the differential diagnosis of solitary cold thyroid nodules. Eur J Nucl Med Mol Imaging 2003; 30(5): 642-650.

14. Alonso O, Mut F, Lago G, Aznarez A, Nuñez M, Canepa J, Touya E. 99Tc(m)-MIBI scanning of the thyroid gland in patients with markedly decreased pertechnetate uptake. Nucl Med Commun 1998; 19(3): 257-261.

15. Foldes I, Levay A, Stotz G. Comparative scanning of thyroid nodules with technetium-99m pertechnetate and technetium-99m methoxyisobutylisonitrile. Eur J Nucl Med 1993; 20(4): 330-333.

16. Nakahara H, Noguchi S, Murakami N, Hoshi H, Jinnouchi S, Nagamachi S, Ohnishi T, Futami S, Flores LG 2nd, Watanabe K. Technetium-99m-sestamibi scintigraphy compared with thallium-201 in evaluation of thyroid tumors. J Nucl Med 1996; 37(6): 901-904.

17. Hurtado-López LM, Arellano-Montaño S, Torres-Acosta EM, Zaldívar-Ramírez FR, Duarte-Torres RM, Alonso-De-Ruiz P, Martínez-Duncker I, Martínez-Duncker C. Combined use of fine-needle aspiration biopsy, MIBI scans and frozen section biopsy offers the best diagnostic accuracy in the assessment of the hypofunctioning solitary thyroid nodule. Eur J Nucl Med Mol Imaging 2004; 31(9): 1273-1279.

18. Sharma R, Mondal A, Shankar LR, Sahoo M, Bhatnagar P, Sawroop K, Chopra MK, Kashyap R. Differentiation of malignant and benign solitary thyroid nodules using 30- and 120-minute tc-99m MIBI scans. Clin Nucl Med 2004; 29(9): 534-537.

19. Boi E, Lai ML, Deias C, Piga M, Serra A, Uccheddu A, Faa G, Mariotti S. The usefulness of 99mTc-SestaMIBI scan in the diagnostic evaluation of thyroid nodules with oncocytic cytology. Eur J Endocrinol 2003; 149(6): 493-498.

20. Sundram EX, Mack P. Evaluation of thyroid nodules for malignancy using 99Tcm-sestamibi. Nucl Med Commun 1995; 16(8): 687-693.

21. Sathekge MM, Mageza RB, Muthuphei MN, Modiba MC, Clauss RC. Evaluation of thyroid nodules with technetium-99m MIBI and technetium-99m pertechnetate. Head Neck 2001; 23(4): 305-310.